NR3C1 and chronic obstructive pulmonary disease: AZD5423 is an inhalable non-steroidal glucocorticoid receptor modulator that is in clinical trials for mild allergic asthma and COPD [44] (clinicaltrials.gov, NCT01226316, accessed July 21, 2023).